vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and 908 Devices Inc. (MASS). Click either name above to swap in a different company.

908 Devices Inc. is the larger business by last-quarter revenue ($17.4M vs $16.7M, roughly 1.0× ASP Isotopes Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs 21.2%). 908 Devices Inc. produced more free cash flow last quarter ($1.3M vs $-47.4M).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

ASPI vs MASS — Head-to-Head

Bigger by revenue
MASS
MASS
1.0× larger
MASS
$17.4M
$16.7M
ASPI
Growing faster (revenue YoY)
ASPI
ASPI
+1274.5% gap
ASPI
1295.7%
21.2%
MASS
More free cash flow
MASS
MASS
$48.7M more FCF
MASS
$1.3M
$-47.4M
ASPI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASPI
ASPI
MASS
MASS
Revenue
$16.7M
$17.4M
Net Profit
$4.2M
Gross Margin
12.5%
52.7%
Operating Margin
17.8%
Net Margin
24.0%
Revenue YoY
1295.7%
21.2%
Net Profit YoY
-586.8%
121.5%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
MASS
MASS
Q4 25
$16.7M
$17.4M
Q3 25
$4.9M
$14.0M
Q2 25
$13.0M
Q1 25
$11.8M
Q4 24
$14.3M
Q3 24
$14.5M
Q2 24
$11.5M
Q1 24
$7.4M
Net Profit
ASPI
ASPI
MASS
MASS
Q4 25
$4.2M
Q3 25
$-12.9M
$-15.0M
Q2 25
$-13.3M
Q1 25
$43.6M
Q4 24
$-19.4M
Q3 24
$-29.3M
Q2 24
$-12.5M
Q1 24
$-10.9M
Gross Margin
ASPI
ASPI
MASS
MASS
Q4 25
12.5%
52.7%
Q3 25
8.7%
52.5%
Q2 25
48.9%
Q1 25
47.0%
Q4 24
46.5%
Q3 24
53.6%
Q2 24
53.8%
Q1 24
52.4%
Operating Margin
ASPI
ASPI
MASS
MASS
Q4 25
17.8%
Q3 25
-306.1%
-116.6%
Q2 25
-116.3%
Q1 25
-93.6%
Q4 24
-116.8%
Q3 24
-168.7%
Q2 24
-74.5%
Q1 24
-102.5%
Net Margin
ASPI
ASPI
MASS
MASS
Q4 25
24.0%
Q3 25
-263.7%
-107.0%
Q2 25
-102.1%
Q1 25
370.2%
Q4 24
-135.6%
Q3 24
-201.8%
Q2 24
-109.5%
Q1 24
-147.1%
EPS (diluted)
ASPI
ASPI
MASS
MASS
Q4 25
$0.09
Q3 25
$-0.15
$-0.41
Q2 25
$-0.37
Q1 25
$1.23
Q4 24
$-0.58
Q3 24
$-0.84
Q2 24
$-0.37
Q1 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
MASS
MASS
Cash + ST InvestmentsLiquidity on hand
$333.3M
$113.0M
Total DebtLower is stronger
$14.4M
Stockholders' EquityBook value
$204.2M
$143.7M
Total Assets
$498.0M
$190.1M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
MASS
MASS
Q4 25
$333.3M
$113.0M
Q3 25
$113.9M
$112.1M
Q2 25
$118.6M
Q1 25
$124.3M
Q4 24
$69.6M
Q3 24
$71.7M
Q2 24
$77.4M
Q1 24
$134.2M
Total Debt
ASPI
ASPI
MASS
MASS
Q4 25
$14.4M
Q3 25
$13.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPI
ASPI
MASS
MASS
Q4 25
$204.2M
$143.7M
Q3 25
$74.1M
$136.3M
Q2 25
$148.8M
Q1 25
$159.4M
Q4 24
$114.6M
Q3 24
$131.0M
Q2 24
$156.4M
Q1 24
$156.9M
Total Assets
ASPI
ASPI
MASS
MASS
Q4 25
$498.0M
$190.1M
Q3 25
$225.9M
$190.9M
Q2 25
$191.7M
Q1 25
$196.0M
Q4 24
$159.5M
Q3 24
$178.3M
Q2 24
$208.8M
Q1 24
$189.8M
Debt / Equity
ASPI
ASPI
MASS
MASS
Q4 25
0.07×
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
MASS
MASS
Operating Cash FlowLast quarter
$-37.8M
$1.3M
Free Cash FlowOCF − Capex
$-47.4M
$1.3M
FCF MarginFCF / Revenue
-284.7%
7.6%
Capex IntensityCapex / Revenue
57.9%
0.0%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$-24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
MASS
MASS
Q4 25
$-37.8M
$1.3M
Q3 25
$-8.9M
$-4.2M
Q2 25
$-5.8M
Q1 25
$-15.0M
Q4 24
$-2.2M
Q3 24
$-5.6M
Q2 24
$-13.0M
Q1 24
$-9.4M
Free Cash Flow
ASPI
ASPI
MASS
MASS
Q4 25
$-47.4M
$1.3M
Q3 25
$-12.0M
$-4.9M
Q2 25
$-5.9M
Q1 25
$-15.2M
Q4 24
$-2.4M
Q3 24
$-5.8M
Q2 24
$-13.7M
Q1 24
$-10.3M
FCF Margin
ASPI
ASPI
MASS
MASS
Q4 25
-284.7%
7.6%
Q3 25
-245.5%
-34.9%
Q2 25
-45.3%
Q1 25
-128.9%
Q4 24
-17.0%
Q3 24
-39.7%
Q2 24
-119.4%
Q1 24
-138.2%
Capex Intensity
ASPI
ASPI
MASS
MASS
Q4 25
57.9%
0.0%
Q3 25
64.4%
4.9%
Q2 25
0.9%
Q1 25
1.4%
Q4 24
1.3%
Q3 24
1.1%
Q2 24
5.6%
Q1 24
12.2%
Cash Conversion
ASPI
ASPI
MASS
MASS
Q4 25
0.32×
Q3 25
Q2 25
Q1 25
-0.34×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPI
ASPI

Segment breakdown not available.

MASS
MASS

Products$14.3M82%
Services$3.0M18%

Related Comparisons